Key Insights

Highlights

Success Rate

84% trial completion

Published Results

17 trials with published results (15%)

Research Maturity

53 completed trials (47% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.8%

10 terminated out of 113 trials

Success Rate

84.1%

-2.4% vs benchmark

Late-Stage Pipeline

16%

18 trials in Phase 3/4

Results Transparency

32%

17 of 53 completed with results

Key Signals

17 with results84% success

Data Visualizations

Phase Distribution

63Total
Not Applicable (27)
P 1 (5)
P 2 (13)
P 3 (13)
P 4 (5)

Trial Status

Completed53
Not Yet Recruiting21
Recruiting20
Terminated10
Active Not Recruiting3
Unknown3

Trial Success Rate

84.1%

Benchmark: 86.5%

Based on 53 completed trials

Clinical Trials (113)

Showing 20 of 20 trials
NCT07566403Not Yet RecruitingPrimary

Overviewing Real-World Outcomes to Boost Interventional Management of CAlcified Coronary Lesions: the OROBICA Registry.

NCT07565805RecruitingPrimary

Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry

NCT07449052Not ApplicableNot Yet RecruitingPrimary

Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease

NCT05698732RecruitingPrimary

Coroflex® ISAR NEO PMCF Study

NCT07318155Phase 2RecruitingPrimary

A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

NCT07552194Not ApplicableNot Yet RecruitingPrimary

Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)

NCT07502703Not Yet Recruiting

Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a Community

NCT07528859TerminatedPrimary

Examining the Effects of Video-Assisted Discharge Education After Coronary Artery Bypass Graft Surgery on Patient Satisfaction and Anxiety

NCT07523880Recruiting

Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD

NCT07479056Not ApplicableRecruiting

Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy

NCT07375810Not Yet RecruitingPrimary

Analysis of ECGio to Predict Coronary Stenosis Against a Mixed Reference Standard

NCT07491107Not Yet RecruitingPrimary

Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary Lesions

NCT07479433RecruitingPrimary

The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI

NCT07477405Not Yet RecruitingPrimary

Drug-coatEd Balloon Multicentric Registry in Spain and PORTugal

NCT07248202Not ApplicableRecruitingPrimary

Ketamine-lidocaine Versus Ketamine-fentanyl for Induction of Anesthesia in Patients With Left Ventricular Systolic Dysfunction Undergoing Elective Coronary Artery Bypass

NCT07476040Not ApplicableNot Yet RecruitingPrimary

Improved Management of Patients With Recent-Onset Stable Chest Pain

NCT07473596Not ApplicableCompletedPrimary

Predictors and Long-term Incidence of In-stent Restenosis After Chronic Total Occlusion Percutaneous Coronary Intervention

NCT07463664Not ApplicableRecruiting

Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions

NCT07444697Recruiting

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07442526Active Not RecruitingPrimary

AGECTO Study: PCI vs. Optimal Medical Therapy for CTO in the Octogenarian Patients

Scroll to load more

Research Network

Activity Timeline